206 related articles for article (PubMed ID: 35755293)
1. NAMPT-targeting PROTAC promotes antitumor immunity
Wu Y; Pu C; Fu Y; Dong G; Huang M; Sheng C
Acta Pharm Sin B; 2022 Jun; 12(6):2859-2868. PubMed ID: 35755293
[TBL] [Abstract][Full Text] [Related]
2. Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation.
Zhu X; Liu H; Chen L; Wu C; Liu X; Cang Y; Jiang B; Yang X; Fan G
Cell Chem Biol; 2022 Nov; 29(11):1616-1629.e12. PubMed ID: 36323324
[TBL] [Abstract][Full Text] [Related]
3. The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia.
Chen X; Zhao S; Song Y; Shi Y; Leak RK; Cao G
Curr Top Med Chem; 2015; 15(21):2211-21. PubMed ID: 26059356
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient Treatment of Ovarian Cancer.
Bi K; Cheng J; He S; Fang Y; Huang M; Sheng C; Dong G
J Med Chem; 2023 Jan; 66(1):1048-1062. PubMed ID: 36563407
[TBL] [Abstract][Full Text] [Related]
5. Drugtamer-PROTAC Conjugation Strategy for Targeted PROTAC Delivery and Synergistic Antitumor Therapy.
He S; Fang Y; Zhu Y; Ma Z; Dong G; Sheng C
Adv Sci (Weinh); 2024 Apr; ():e2401623. PubMed ID: 38639391
[TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of nampt in human islets.
Kover K; Tong PY; Watkins D; Clements M; Stehno-Bittel L; Novikova L; Bittel D; Kibiryeva N; Stuhlsatz J; Yan Y; Ye SQ; Moore WV
PLoS One; 2013; 8(3):e58767. PubMed ID: 23536823
[TBL] [Abstract][Full Text] [Related]
7. Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin.
Carbone F; Liberale L; Bonaventura A; Vecchiè A; Casula M; Cea M; Monacelli F; Caffa I; Bruzzone S; Montecucco F; Nencioni A
Compr Physiol; 2017 Mar; 7(2):603-621. PubMed ID: 28333382
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function.
Caton PW; Kieswich J; Yaqoob MM; Holness MJ; Sugden MC
Diabetologia; 2011 Dec; 54(12):3083-92. PubMed ID: 21901281
[TBL] [Abstract][Full Text] [Related]
9. Making Protein Degradation Visible: Discovery of Theranostic PROTACs for Detecting and Degrading NAMPT.
Cheng J; He S; Xu J; Huang M; Dong G; Sheng C
J Med Chem; 2022 Dec; 65(23):15725-15737. PubMed ID: 36442664
[TBL] [Abstract][Full Text] [Related]
10. Dual-Programmable Semiconducting Polymer NanoPROTACs for Deep-Tissue Sonodynamic-Ferroptosis Activatable Immunotherapy.
Wang F; Dong G; Ding M; Yu N; Sheng C; Li J
Small; 2024 Feb; 20(8):e2306378. PubMed ID: 37817359
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide phosphoribosyltransferase and the hypothalamic-pituitary-adrenal axis of the rat.
Celichowski P; Jopek K; Milecka P; Szyszka M; Tyczewska M; Malendowicz LK; Ruciński M
Mol Med Rep; 2018 Apr; 17(4):6163-6173. PubMed ID: 29436637
[TBL] [Abstract][Full Text] [Related]
12. Intracellular Nampt impairs esophageal squamous cell carcinoma neo-adjuvant chemotherapy response independent of eNampt.
Liu J; Che X; You J; Zhang G; Zhao R; Fu J; Li H
Am J Transl Res; 2021; 13(3):1411-1421. PubMed ID: 33841666
[TBL] [Abstract][Full Text] [Related]
13. Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1.
Hu M; Zhou W; Wang Y; Yao D; Ye T; Yao Y; Chen B; Liu G; Yang X; Wang W; Xie Y
Acta Pharm Sin B; 2020 Oct; 10(10):1943-1953. PubMed ID: 33163345
[TBL] [Abstract][Full Text] [Related]
14. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism.
Li Y; Zhang Y; Dorweiler B; Cui D; Wang T; Woo CW; Brunkan CS; Wolberger C; Imai S; Tabas I
J Biol Chem; 2008 Dec; 283(50):34833-43. PubMed ID: 18945671
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.
Bermudez B; Dahl TB; Medina I; Groeneweg M; Holm S; Montserrat-de la Paz S; Rousch M; Otten J; Herias V; Varela LM; Ranheim T; Yndestad A; Ortega-Gomez A; Abia R; Nagy L; Aukrust P; Muriana FJG; Halvorsen B; Biessen EAL
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1157-1167. PubMed ID: 28408371
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide Phosphate Transferase (NAMPT) Increases in Plasma in Patients with Acute Coronary Syndromes, and Promotes Macrophages to M2 Polarization.
Zhang C; Zhu R; Wang H; Tao Q; Lin X; Ge S; Zhai Z
Int Heart J; 2018 Sep; 59(5):1116-1122. PubMed ID: 30158377
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide phosphoribosyltransferase in malignancy: a review.
Shackelford RE; Mayhall K; Maxwell NM; Kandil E; Coppola D
Genes Cancer; 2013 Nov; 4(11-12):447-56. PubMed ID: 24386506
[TBL] [Abstract][Full Text] [Related]
19. Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia.
Audrito V; Serra S; Brusa D; Mazzola F; Arruga F; Vaisitti T; Coscia M; Maffei R; Rossi D; Wang T; Inghirami G; Rizzi M; Gaidano G; Garcia JG; Wolberger C; Raffaelli N; Deaglio S
Blood; 2015 Jan; 125(1):111-23. PubMed ID: 25368373
[TBL] [Abstract][Full Text] [Related]
20. Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4.
Colombo G; Travelli C; Porta C; Genazzani AA
iScience; 2022 Apr; 25(4):104147. PubMed ID: 35402885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
